Debate - PRO: TEVAR in the subacute phase is the treatment of choice for patients with uncomplicated type B aortic dissection

Document Type

Presentation

Publication Date

8-8-2023

Keywords

oregon; cards; cards presentation

Clinical Institute

Cardiovascular (Heart)

Specialty/Research Institute

Cardiology

Comments

Podium talk presented at UCSF Vascular Symposium, August 8, 2023, Napa, CA

This document is currently not available here.


Share

COinS